Enel Américas S.A (ENELAM)
Santiago Stock Exchange · Chile · prices in CLP · close of 27 Oct 2026
Key indicators
| Last close | CLP 82.90 |
|---|---|
| 52-week range | 73.95 – 93.93 |
| Return, 1 month / 3 months | −0.1% / −3.5% |
| Return, 1 year / 3 years | −5.1% / +2.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -16.4% |
| Average daily value traded | 4,852.16M CLP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Enel Américas is an electricity company based in Chile that generates, distributes and supplies power across several Latin American countries. It serves homes, businesses and industries through regulated distribution networks and generation plants, with operations spanning markets such as Brazil, Colombia, Peru and Argentina. The company's activities cover the production of electricity from various sources and its delivery to end customers, making it a utility focused on the provision of essential power services in the region.
The shares are listed on the Santiago Stock Exchange in Chile under the code ENELAM, and the price on this page is in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Enel Américas S.A (ENELAM) trades on the Santiago Stock Exchange in Chile. It last closed at CLP 82.90 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 56 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.1% and over the last three months it fell 3.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Santiago Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -11.2% | ||
| Momentum | 32 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.5% | ||
| 6-month return | -0.5% | ||
| 12-month return, skipping the last month | -5.0% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.4% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 4,852.16M CLP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −8.8% |
|---|---|
| 1 month | −0.1% |
| 3 months | −3.5% |
| 6 months | −0.5% |
| 1 year | −5.1% |
| 3 years | +2.8% |
| 5 years | +0.2% |
Signals
| 50-day / 200-day average | 86.80 / 82.19 |
|---|---|
| Golden / death cross (60 days) | Golden, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | USD 1.8329 |
| 19 Jan 2026 | USD 0.9194 |
| 26 May 2025 | USD 3.7338 |
| 27 Jan 2025 | USD 3.3961 |
| 24 May 2024 | USD 1.3014 |
| 6 Feb 2024 | USD 1.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Santiago Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.